Your browser doesn't support javascript.
loading
Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue.
Gelsomino, Francesco; Vitale, Giovanni; Raschi, Emanuel; Ardizzoni, Andrea.
Afiliación
  • Gelsomino F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy. Electronic address: francesco_gelsomino@aosp.bo.it.
  • Vitale G; Internal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Ardizzoni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy.
J Thorac Oncol ; 18(10): e112-e113, 2023 10.
Article en En | MEDLINE | ID: mdl-37758348
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2023 Tipo del documento: Article